Debut Plus

₹657.5

▼ -25.47 -3.73%

17 Jul 2026

NSE Listed

Akums Drugs And Pharma Limited (AKUMS)

Volume: 1,04,424Avg Vol 1W: 4,08,885.8Avg Vol 1M: 3,63,076.252W Range:₹409.3₹714.7
NSE BSE www.akums.in
Key Ratios
Checked 5h ago
Market Cap₹10,967 Cr
Current Price₹657.5
Previous Close₹682.97
High / Low (52w)₹714.7 / ₹409.3
Volume1,04,424
Avg Vol (1W)4,08,885.8
Avg Vol (1M)3,63,076.2
Stock P/E45.11
Book Value₹150.57
Dividend Yield—
ROE13.2%
ROA—
Revenue (TTM)₹4,170 Cr
Revenue Growth—
Profit Margin—
Total Debt₹0 Cr
Shares Outstanding—
Face Value₹2
EPS (TTM)₹10.52
P/B3.15
Debt / Equity0.13
50 DMA₹596.25
200 DMA₹499.01
Day change-3.73%
Price Chart
₹657.5▲ 17.37% · 1Y
₹702₹41439.7L
2025-07-17
2026-07-16

20-day avg volume: 3.6L shares

Pros
  • Company is almost debt-free.
Cons
  • Revenue fell 11% YoY.
Quarterly Results
MetricJun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Revenue₹1,019 Cr₹1,033 Cr₹1,010 Cr₹1,056 Cr₹1,024 Cr₹1,018 Cr₹1,160 Cr₹1,158 Cr
EBITDA₹101 Cr₹100 Cr₹91 Cr₹71 Cr₹119 Cr₹89 Cr₹142 Cr₹147 Cr
Net Profit₹60 Cr₹65 Cr₹65 Cr₹148 Cr₹63 Cr₹41 Cr₹66 Cr₹85 Cr
EPS————————
Profit & Loss (Annual)
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue₹2,442 Cr₹2,744 Cr₹3,695 Cr₹3,745 Cr₹4,212 Cr₹4,170 Cr₹4,488 Cr
EBITDA₹135 Cr₹189 Cr₹-164 Cr₹271 Cr₹31 Cr₹363 Cr₹496 Cr
Net Profit₹44 Cr₹123 Cr₹-253 Cr₹95 Cr₹-4 Cr₹338 Cr₹255 Cr
EPS357.038.58-17.656.63-0.2822.616.67
Balance Sheet
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets₹2,078 Cr₹2,167 Cr₹3,069 Cr₹3,267 Cr₹3,516 Cr₹4,113 Cr₹5,447 Cr
Total Liabilities₹1,357 Cr₹1,280 Cr₹2,444 Cr₹2,543 Cr₹2,796 Cr₹1,050 Cr₹2,116 Cr
Equity₹721 Cr₹887 Cr₹625 Cr₹723 Cr₹720 Cr₹3,064 Cr₹3,331 Cr
Total Debt———————
Cash Flow
MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating₹77 Cr₹176 Cr₹87 Cr₹274 Cr₹561 Cr₹546 Cr₹1,269 Cr
Investing₹-190 Cr₹-109 Cr₹-235 Cr₹-305 Cr₹-330 Cr₹-548 Cr₹-930 Cr
Financing₹233 Cr₹-91 Cr₹236 Cr₹125 Cr₹-108 Cr₹73 Cr₹34 Cr
Free Cash Flow₹77 Cr₹176 Cr₹87 Cr₹274 Cr₹561 Cr₹546 Cr₹1,269 Cr
Shareholding
Promoter 75.26% Institutions 15.72% Public 9.02%
About Akums Drugs And Pharma Limited

Healthcare · Drug Manufacturers - Specialty & Generic

Akums Drugs and Pharmaceuticals Limited manufactures and sells pharmaceutical products and active pharmaceutical ingredients India and internationally. The company provides drugs, ayurvedic, nutraceuticals, food and dietary supplements, derma and cosmetics, healthcare and hospital products, over-the-counter (OTC) products, active pharmaceutical ingredients, excipients, and compounds. It also offers branded formulations on various dosage forms, including tablets, hard and soft gelatin capsules, liquid orals, sachets, vials, ampoules, form-fill-seal products, topical preparations, eye drops, dry powder injections, and gummies for therapeutic areas, such as antiinfectives, pain management, gastroenterology, orthopaedics, cardio-diabetic care, critical care, respiratory, and gynaecology. In addition, the company operates as pharmaceutical contract development and manufacturing company. Akums Drugs and Pharmaceuticals Limited was incorporated in 2004 and is based in Delhi, India.

www.akums.in ↗
Efficiency & Working Capital
ROCE10.9%
Interest Coverage5.1
Dividend Payout—
Debtor Days67 d
Inventory Days63 d
Payable Days50 d
Cash Conversion Cycle80 d
Working Capital Days130 d
Shareholding Details

As of 2026-03-31

Promoter75.3%
FII1.4%
DII14.3%
Institutions15.7%
Public9%
Promoter Pledge0%
No. of Shareholders72,589
Shareholding Pattern

Quarterly — figures in %. Latest 11 quarters.

PeriodFeb 2024Feb 2024Aug 2024Aug 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Promoters84.9%84.9%75.3%75.3%75.3%75.3%75.3%75.3%75.3%75.3%75.3%
FIIs0%0%5.3%5.3%7.3%6.4%5.8%4.2%2.3%1.1%1.4%
DIIs15.1%0%7.6%6.4%7.5%7%7.4%8.9%9.3%14.4%14.3%
Public0%15.1%6.4%13%9.9%11.4%11.6%11.7%13.2%9.2%9%
Promoter Pledge0%0%0%0%0%0%0%0%0%0%0%
No. of Shareholders881,38,2051,38,20557,53168,41069,36669,42475,36576,86972,589
Returns History (ROE / ROCE / ROA)
PeriodROEROCEROAP/E
202603————
Major Shareholders (>1%)
NameCategoryStakeShares
Akums Master Trust (sanjeev Jain And Sandeep Jain)Shareholding of Promoter and Promoter Group40.8%6.42 Cr
Sandeep JainShareholding of Promoter and Promoter Group17.2%2.71 Cr
Sanjeev JainShareholding of Promoter and Promoter Group17.2%2.71 Cr
Icici Prudential Pharma Healthcare And Diaganostics (p.h.d) FundPublic Shareholding4.6%71,76,551
Franklin India Opportunites FundPublic Shareholding4.2%65,73,679
Bandhan Small Cap FundPublic Shareholding1.1%17,44,343
Lata JainShareholding of Promoter and Promoter Group0%13,750
Anita JainShareholding of Promoter and Promoter Group0%0
Anuradha PalShareholding of Promoter and Promoter Group0%100
Archana JainShareholding of Promoter and Promoter Group0%0
Kiran JainShareholding of Promoter and Promoter Group0%0
Kusum JainShareholding of Promoter and Promoter Group0%0
Rajesh SharmaShareholding of Promoter and Promoter Group0%0
Rajiv MittalShareholding of Promoter and Promoter Group0%0
Shivangi JainShareholding of Promoter and Promoter Group0%0
Arushi JainShareholding of Promoter and Promoter Group0%0
Umang JainShareholding of Promoter and Promoter Group0%0
Kanishk JainShareholding of Promoter and Promoter Group0%0
Manan JainShareholding of Promoter and Promoter Group0%0
Ausl Trust (sanjeev Jain)Shareholding of Promoter and Promoter Group0%0
Sandeep Jain Trust (sandeep Jain)Shareholding of Promoter and Promoter Group0%0
Akome Lifecare Private LimitedShareholding of Promoter and Promoter Group0%0
Akum Impex LlpShareholding of Promoter and Promoter Group0%0
Akums FoundationShareholding of Promoter and Promoter Group0%0
American Remedies Lifesciences LimitedShareholding of Promoter and Promoter Group0%0
Promoter Pledges
HolderPledged Shares% of HoldingAs of
Sandeep Jain00%2026-03-31
Sanjeev Jain00%2026-03-31
Lata Jain00%2026-03-31
Anita Jain00%2026-03-31
Anuradha Pal00%2026-03-31
Archana Jain00%2026-03-31
Kiran Jain00%2026-03-31
Kusum Jain00%2026-03-31
Rajesh Sharma00%2026-03-31
Rajiv Mittal00%2026-03-31
Shivangi Jain00%2026-03-31
Arushi Jain00%2026-03-31
Board of Directors
NameDesignationYear
SANJEEV JAINED / MD / Promoter2026
SANDEEP JAINED / MD / Promoter2026
Sanjay SinhaWhole-time Director2026
Kewal HandaIndependent Non Exe. Director2026
Matangi GowrishankarIndependent Non Exe. Director2026
SATWINDER SINGHIndependent Non Exe. Director2026
SUNIL KUMAR THAKURNon-Exec & Non-Independent Dir2026
Anil Kumar Arvindlal AminIndependent Non Exe. Director2026
DHARAMVIR MALIKCompany Sec. & Compli. Officer2026
Segments — Product
SegmentRevenueShare
Pharmaceuticals₹0 Cr—
Capital Structure (₹ Cr)
YearFace ValueAuthorisedIssuedPaid-up
2026₹2403131
Corporate Actions
TypeDateValueRemark
dividend2026-07-03₹1.0 (50.0%)Final
dividend2026-07-03₹2.0 (100.0%)Special
dividend2026-07-03₹1 (50%)Final
dividend2026-07-03₹2 (100%)Special
Related-Party Transactions (₹ Cr)
YearSubsidiariesAssociatesJVKMPOthersTotal
20262,4000023752,499
20262,003000322,035
202634001035
Substantial Acquisitions (SAST)

1 disclosure(s)

Block Deal22/12/2025 · 72,78,535
Company Information
Incorporated2004
AuditorWalker Chandiok & Co LLP
Investor Email[email protected]
🌐 www.akums.in ↗

📍 304 Mohan Place LSC Saraswati, Vihar, Delhi, Delhi, 110034

Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

Log inSign up free

More stocks

AKG Exim LimitedAKI India LimitedAkiko Global Services LimitedAkshar Spintex LimitedAksharChem India LimitedAksh Optifibre Ltd.Alankit LimitedAlbert DavidAlcokraft Distillerie Ltd.Alembic LimitedAlgoquant Fintech LimitedAlicon Castalloy LimitedAll “A” stocks →

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search